(Q35024453)

16 June 2018

review article

1 reference

title

Colony-stimulating factors for the management of neutropenia in cancer patients (English)

1 reference

16 June 2018

author

Carmen R Domingo

1 reference

ORCID Public Data File 2021

author name string

David C Dale

series ordinal

1

1 reference

16 June 2018

publication date

1 January 2002

1 reference

16 June 2018

published in

Drugs

1 reference

16 June 2018

volume

62 Suppl 1

1 reference

16 June 2018

issue

1

1 reference

12364823

22 April 2018

http://europepmc.org/abstract/MED/12364823

page(s)

1-15

1 reference

16 June 2018

Effect of granulocyte colony-stimulating factor treatment on ex vivo neutrophil functions in nonneutropenic surgical intensive care patients.

cites work

1 reference

12 December 2020

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

1 reference

12 December 2020

Mobilization of CD34+ progenitor cells by granulocyte colony-stimulating factor in human immunodeficiency virus type 1-infected adults

1 reference

12 December 2020

Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction.

1 reference

12 December 2020

Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.

1 reference

12 December 2020

Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncolo

1 reference

12 December 2020

Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children

1 reference

12 December 2020

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin

1 reference

12 December 2020

Bacillus cereus bacteremia and meningitis in immunocompromised children

1 reference

12 December 2020

The therapeutic use of hematopoietic growth factors

1 reference

12 December 2020

Biopharmaceutical drug development: Filgrastim (r-metHuG-CSF) use in patients with HIV infection

1 reference

12 December 2020

Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia

1 reference

12 December 2020

Clinical experience with Filgrastim in AIDS.

1 reference

12 December 2020

Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia

1 reference

12 December 2020

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

12 December 2020

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

12 December 2020

The use of granulocyte colony-stimulating factor after liver transplantation

1 reference

12 December 2020

Human immunodeficiency virus disease-related neutropenia and the risk of hospitalization for bacterial infection

1 reference

12 December 2020

Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells

1 reference

12 December 2020

A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).

1 reference

12 December 2020

A predictive model for neutropenia associated with cancer chemotherapy

1 reference

12 December 2020

Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up

1 reference

12 December 2020

Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients

1 reference

12 December 2020

Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study

1 reference

12 December 2020

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

1 reference

12 December 2020

Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia

1 reference

12 December 2020

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

1 reference

12 December 2020

Comparative safety of filgrastim versus sargramostim in patients receiving myelosuppressive chemotherapy

1 reference

12 December 2020

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.

1 reference

12 December 2020

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia

1 reference

12 December 2020

Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer

1 reference

12 December 2020

Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma

1 reference

12 December 2020

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.

1 reference

12 December 2020

Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma

1 reference

12 December 2020

A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy

1 reference

12 December 2020

The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy

1 reference

12 December 2020

Hematopoietic growth factors in the reduction of chemotherapeutic toxicity

1 reference

12 December 2020

The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group

1 reference

12 December 2020

Sequence-dependent toxicity profile in modified FAMTX (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: a feasibility study

1 reference

12 December 2020

Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

1 reference

12 December 2020

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

12 December 2020

Use of granulocyte colony-stimulating factor (G-CSF) in clinical practice in Fukuoka City area in Japan

1 reference

12 December 2020

Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: role of the tumor necrosis factor ligand-receptor system

1 reference

12 December 2020

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial

1 reference

12 December 2020

The emergence of peripheral blood progenitor cells to support intensive chemotherapy for patients with breast cancer

1 reference

12 December 2020

The pharmacodynamic basis for the increased antileukaemic efficacy of cytosine arabinoside-based treatment regimens in acute myeloid leukaemia with a high proliferative activity

1 reference

12 December 2020

Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy

1 reference

12 December 2020

Haematopoietic growth factors in children with neutropenia

1 reference

12 December 2020

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia

1 reference

12 December 2020

Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial

1 reference

12 December 2020

Impact of colony-stimulating factor therapy on clinical outcome and frequency rate of nosocomial infections in intensive care unit neutropenic patients

1 reference

12 December 2020

Hematopoietic growth factors in acute myeloid leukemia: supportive and priming effects

1 reference

12 December 2020

Ceftriaxone plus once daily aminoglycoside with filgrastim for treatment of febrile neutropenia: early hospital discharge vs. Standard In-patient care

1 reference

12 December 2020

Optimizing adjuvant breast cancer chemotherapy: rationale for the MA.21 study

1 reference

12 December 2020

A1 is a constitutive and inducible Bcl-2 homologue in mature human neutrophils

1 reference

12 December 2020

The addition of allogeneic peripheral blood-derived progenitor cells to bone marrow for transplantation: results of a randomised clinical trial

1 reference

12 December 2020

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

1 reference

12 December 2020

Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma

1 reference

12 December 2020

Role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of patients with HIV infection.

1 reference

12 December 2020

Peripheral blood progenitor cell transplantation for breast cancer: pharmacoeconomic considerations.

1 reference

12 December 2020

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Ran

1 reference

12 December 2020

Hematopoietic growth factors

1 reference

12 December 2020

1 reference

12 December 2020

Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy

1 reference

12 December 2020

Use of G-CSF to Sustain Dose Intensity in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Pilot Study

1 reference

12 December 2020

Phase I study of accelerated FEC with granulocyte colony-stimulating factor (Lenograstim) support

1 reference

12 December 2020

Recombinant human granulocyte colony-stimulating factor increases circulating CD34-postive cells in patients with AIDS.

1 reference

12 December 2020

Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

12 December 2020

Community-acquired pneumonia in the elderly: association of mortality with lack of fever and leukocytosis

1 reference

12 December 2020

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

12 December 2020

Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells

1 reference

12 December 2020

Hematopoietic growth factors for the treatment of severe chronic neutropenia

1 reference

12 December 2020

Factors influencing collection and engraftment of CD34+ cells in patients with breast cancer following high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation

1 reference

12 December 2020

Optimal timing (Preemptive versus supportive) of granulocyte colony-stimulating factor administration following high-dose cyclophosphamide

1 reference

12 December 2020

Effect of preoperative prophylaxis with filgrastim in cancer neck dissection

1 reference

12 December 2020

Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy

1 reference

12 December 2020

The economics of febrile neutropenia: implications for the use of colony-stimulating factors

1 reference

12 December 2020

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

12 December 2020

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

1 reference

12 December 2020

The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?

1 reference

12 December 2020

G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial

1 reference

12 December 2020

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

12 December 2020

Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings

1 reference

12 December 2020

Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology

1 reference

12 December 2020

Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy

1 reference

12 December 2020

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors

1 reference

12 December 2020

High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.

1 reference

12 December 2020

Use of granulocyte colony-stimulating factor in the treatment of acute infectious diseases

1 reference

12 December 2020

Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission

1 reference

12 December 2020

Expression of CD11b/CD18 on neutrophils after consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell transplantation

1 reference

12 December 2020

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer

1 reference

12 December 2020

Granulocyte colony-stimulating factor: its potential role in infectious disease

1 reference

12 December 2020

Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomised, placebo-controlled trial in AIDS patients

1 reference

12 December 2020

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group

1 reference

12 December 2020

Escalating drug delivery in cancer chemotherapy: a review of concepts and practice--Part 2.

1 reference

12 December 2020

Identifiers

DOI

10.1159/000064387

1 reference

16 June 2018

1 reference

16 June 2018